IP Verse

Composition For Preventing And Treating Pancreatitis Containing Naphthoquinone-Based Compound As Active Ingredient

Patent No. EP3284464 (titled "Composition For Preventing And Treating Pancreatitis Containing Naphthoquinone-Based Compound As Active Ingredient") was filed by Nadianbio on Apr 18, 2016. The application was issued on Aug 13, 2025.

Patent Summary

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Aug 26, 2025
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 17, 2025
Decision to grant a European patent
Jul 7, 2025
(Electronic) Receipt
Jul 7, 2025
Filing of the translations of the claims
Jul 7, 2025
French translation of claims
Jul 7, 2025
German translation of the claims
Jul 7, 2025
Letter accompanying subsequently filed items
Mar 6, 2025
Annex to the communication about intention to grant a European patent
Mar 6, 2025
Bibliographic data of the European patent application
Mar 6, 2025
Communication about intention to grant a European patent
Mar 6, 2025
Intention to grant (signatures)
Mar 6, 2025
Text intended for grant (clean copy)
Mar 6, 2025
Text intended for grant (version for approval)
Dec 20, 2023
(Electronic) Receipt
Dec 20, 2023
Amended description with annotations
Dec 20, 2023
Amended drawings with annotations
Dec 20, 2023
Description
Dec 20, 2023
Drawings
Dec 20, 2023
Letter accompanying subsequently filed items
Dec 20, 2023
Reply to communication from the Examining Division
Dec 18, 2023
Grant of extension of time limit (examination procedure)
Dec 12, 2023
(Electronic) Receipt
Dec 12, 2023
Request for extension of time limit to communication from the Examining Division
Oct 2, 2023
Annex to the communication
Oct 2, 2023
Communication from the Examining Division
Jun 13, 2023
Response to enquiry for communication from the Examining Division
May 31, 2023
(Electronic) Receipt
May 31, 2023
Enquiry as to the processing of the file
May 31, 2023
Letter accompanying subsequently filed items
Sep 27, 2021
(Electronic) Receipt
Sep 27, 2021
Amended claims with annotations
Sep 27, 2021
Claims
Sep 27, 2021
Letter accompanying subsequently filed items
Sep 27, 2021
Reply to communication from the Examining Division
Jul 30, 2021
Grant of extension of time limit (examination procedure)
Jul 26, 2021
(Electronic) Receipt
Jul 26, 2021
Request for extension of time limit to communication from the Examining Division
Mar 15, 2021
Annex to the communication
Mar 15, 2021
Communication from the Examining Division
Feb 26, 2021
Examination started
Dec 23, 2020
Response to enquiry for communication from the Examining Division
Dec 9, 2020
(Electronic) Receipt
Dec 9, 2020
Enquiry as to the processing of the file
Dec 9, 2020
Letter accompanying subsequently filed items
Mar 27, 2019
Communication concerning corrected entries of the applicant
Mar 13, 2019
Communication of amended entries concerning the representative
Mar 12, 2019
Communication concerning the filing of a power of attorney
Mar 6, 2019
(Electronic) Receipt
Mar 6, 2019
Authorisation
Mar 6, 2019
Letter accompanying subsequently filed items
Mar 6, 2019
Request for correction of client data
May 22, 2018
(Electronic) Receipt
May 22, 2018
Amended claims filed after receipt of (European) search report
May 22, 2018
Amended claims with annotations
May 22, 2018
Amendments received before examination
May 22, 2018
Letter accompanying subsequently filed items
Mar 22, 2018
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Mar 5, 2018
Communication regarding the transmission of the European search report
Mar 5, 2018
European search opinion
Mar 5, 2018
Information on Search Strategy
Mar 5, 2018
Supplementary European search report
Feb 22, 2018
Search started
Jan 24, 2018
Notification of forthcoming publication
Nov 22, 2017
Communication to designated inventor
Nov 22, 2017
Communication to designated inventor
Nov 22, 2017
Communication to designated inventor
Nov 2, 2017
(Electronic) Receipt
Nov 2, 2017
Abstract
Nov 2, 2017
Amended claims filed after receipt of (European) search report
Nov 2, 2017
Amended drawings filed after receipt of (European) search report
Nov 2, 2017
Claims
Nov 2, 2017
Converted Sequence Listing
Nov 2, 2017
Description
Nov 2, 2017
Drawings
Nov 2, 2017
Request for entry into the European phase
Oct 31, 2017
Copy of the international preliminary report on patentability
Oct 31, 2017
Translation of the international preliminary report on patentability
Aug 25, 2017
Information on entry into European phase
Dec 8, 2016
Copy of the international search report
Dec 8, 2016
Copy of the translated international search report
Dec 8, 2016
International publication of the international search report
Nov 7, 2016
Priority document (electronically transmitted)
Oct 20, 2016
International publication pamphlet
Oct 20, 2016
Sequence listing

EP3284464

NADIANBIO

Application Number: EP16780345A
Filing Date: Apr 18, 2016
Status: Granted And Under Opposition; Jul 11, 2025
Publication Date: Aug 13, 2025
External Links: Slate, Register , Google Patents